Stock Options (Detail Narrative) - USD ($) |
1 Months Ended | 12 Months Ended | ||
---|---|---|---|---|
May 11, 2023 |
Oct. 27, 2023 |
Aug. 31, 2023 |
Aug. 31, 2022 |
|
Description of incentives plan | The Company established an Equity Incentive Plan whereby our Board, pursuant to shareholder approved amendments, may grant up to 809,165 stock options to directors, officers, employees, and consultants with such number being increased to up to 10% of the issued share capital at the end of each calendar year, at the discretion of the board, pursuant to an evergreen formula. While these amendments have been approved by the Company’s shareholders, the Company has not filed an S-8 Registration Statement to register these additional securities, accordingly, until such S-8 Registration Statement is filed with the SEC, the Company may only issue up to 510,433 shares under the current registered Equity Incentive Plan | |||
Number of stock options, granted | 267,969 | |||
Fair value of options awarded | $ 89,057 | $ 680,511 | ||
Exercise price | $ 0.95 | $ 1.15 | $ 1.75 | $ 4.21 |
Stock based compensation expense | $ 170,382 | $ 752,591 | ||
Unrecognized non-cash compensation costs | $ 89,057 | |||
Non-vested stock options | 56,131 | |||
Compensation expense for options repricing | $ 25,194 | |||
Stock Options | ||||
Exercise price repriced | $ 3 | |||
Options repricing | 267,969 | |||
Weighted Average Remaining Contractual Life | 10 years | |||
Minimum | Stock Options | ||||
Exercise price | $ 9.60 | |||
Maximum | Stock Options | ||||
Exercise price | $ 4.80 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition This item represents the estimated amount of gains or losses included in earnings during the period attributable to changes in instrument-specific credit risk arising from loans and other receivables held as assets. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Description of terms of share-based payment arrangement. Includes, but is not limited to, type of award or grantee and reason for issuance. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|